Emerson reports fourth quarter and full year 2023 results; provides initial 2024 outlook

St. louis , nov. 7, 2023 /prnewswire/ -- emerson (nyse: emr) today reported results for its fourth quarter and fiscal year ended september 30, 2023, which are presented on a continuing operations basis. emerson also declared a quarterly cash dividend of $0.525 per share of common stock payable december 11, 2023 to stockholders of record november 17, 2023.
EMR Ratings Summary
EMR Quant Ranking